// App-Quantinova.ai

2958 : Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus

Researchers

Presenter

  • Hermine I. Brunner

Principal Investigators

  • Michael W. Beresford

  • Nicolino Ruperto

  • Stacy P. Ardoin

  • Simone Appenzeller

  • Clovis A Silva

  • Glaucia V. Novak

  • Daniela M. Loureno

  • Francisco Flores

  • Beatrice Goilav

  • Scott E. Wenderfer

  • Deborah M. Levy

  • Angelo Ravelli

  • Raju Khubchandani

  • Tadej Avcin

  • Marisa S. Klein-Gitelman

  • Brian M. Feldman

  • Jun Ying

Medical Centers

  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • Pediatric Residency Program, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • On Behalf of the UK JSLE Study Group, Liverpool, United Kingdom

  • Istituto Giannina Gaslini, Genoa, Italy

  • Pediatric Rheumatology Unit, State University of Campinas, Sao Paulo, Brazil

  • Medical resident, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo,Brazil

  • Medical resident, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo,Brazil

  • Division of Nephrology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

  • Division of Psychology, Baylor College of Medicine, Texas Childrens Hospital, Houston, TX

  • University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada

  • University of Genoa, Istituto Giannina Gaslini, Genoa, Italy

  • Department of Paediatrics, Jaslok Hospital and Research Center, Mumbai, India

  • Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, GENOA, Italy

  • Division of Pediatric Rheumatology/PDD PTD, Lurie Children's Hospital of Chicago/Northwestern University, Chicago, IL

  • Hospital for Sick Children, Toronto, ON, Canada

  • Center for Biostatistical Services, University of Cincinnati College of Medicine, Cincinnati, OH

Locations

  • United States

  • United Kingdom

  • Italy

  • Brazil

  • Canada

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved